Brazil’s Health Regulator Briefly Suspends Hapvida Premium Hikes, Exposing Sector Volatility

Brazil’s ANS briefly halted Hapvida’s planned premium hikes affecting nearly 1 million policyholders, only to reverse the decision a day later.